Drug profile · INN
glycerol phenylbutyrate
RAVICTI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
glycerol phenylbutyrate (RAVICTI) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN glycerol phenylbutyrate
Brand RAVICTI
Route ORAL
Formulation LIQUID
ATC code A16AX09
Originator Teva Pharma GmbH
Frequently asked questions
What is glycerol phenylbutyrate?
glycerol phenylbutyrate (RAVICTI) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for glycerol phenylbutyrate?
RAVICTI is a marketed brand name for glycerol phenylbutyrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glycerol phenylbutyrate?
glycerol phenylbutyrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.